Similar articles

• [Chronic hepatitis C in hemodialysis patients].

  Tanaka H, Ueda H, Ichinose M, Miyano M. Tanaka H, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):645-8. Nihon Rinsho. 2004. PMID: 15359877 Review. Japanese. No abstract available.
• [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].

  Nishiguchi S, Kubo S, Shiomi S. Nishiguchi S, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):600-4. Nihon Rinsho. 2004. PMID: 15359868 Review. Japanese. No abstract available.
• [Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].

  Yamada G. Yamada G. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):590-5. Nihon Rinsho. 2004. PMID: 15359866 Review. Japanese. No abstract available.
• Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.

  Shindo M, Ken A, Okuno T. Shindo M, et al. Cancer. 1999 May 1;85(9):1943-50. Cancer. 1999. PMID: 10223234
• [Treatment of hepatitis C virus-related cirrhosis].

  Bronowicki JP. Bronowicki JP. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B220-4. Gastroenterol Clin Biol. 2002. PMID: 12180292 Review. French. No abstract available.